http://nar.oxfordjournals.org/cgi/content/full/36/15/4913
free full text
Imaging and characterizing influenza A virus mRNA transport in living cells
<nobr>Wei Wang<sup>1</sup><sup>,2</sup></nobr>, <nobr>Zong-Qiang Cui<sup>1</sup></nobr>, <nobr>Han Han<sup>1</sup><sup>,2</sup></nobr>, <nobr>Zhi-Ping Zhang<sup>1</sup></nobr>, <nobr>Hong-Ping Wei<sup>1</sup></nobr>, <nobr>Ya-Feng Zhou<sup>1</sup></nobr>, <nobr>Ze Chen<sup>1</sup></nobr> and <nobr>Xian-En Zhang<sup>1</sup><sup>,*</sup></nobr> <sup>1</sup>State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071 and <sup>2</sup>Graduate School, Chinese Academy of Sciences, Beijing 100039, China
[SIZE=-1]*To whom correspondence should be addressed. Tel: +86 10 5888 1508; Fax: +86 10 5888 1559; Email: x.zhang@wh.iov.cn<script type="text/javascript"><!-- var u = "x.zhang", d = "wh.iov.cn"; document.getElementById("em0").innerHTML = '<a href="mailto:' + u + '@' + d + '">' + u + '@' + d + '<\/a>'//--></script>[/SIZE]
[SIZE=-1]Received April 4, 2008.[/SIZE] [SIZE=-1]Revised June 23, 2008.[/SIZE] [SIZE=-1]Accepted July 8, 2008.[/SIZE]
<!-- null -->
<table width="100%" bgcolor="#e1e1e1" cellpadding="0" cellspacing="0"> <tbody><tr><td valign="middle" width="5%" align="left" bgcolor="#ffffff">
</td> <th valign="middle" width="95%" align="left">[SIZE=+2] ABSTRACT [/SIZE]</th></tr></tbody></table> <table align="right" border="1" cellpadding="5"><tbody><tr><th align="left">[SIZE=-1] 
[/SIZE]</th></tr></tbody></table>
The mechanisms of influenza A virus mRNA intracellular transport<sup> </sup>are still not clearly understood. Here, we visualized the distribution<sup> </sup>and transport of influenza A virus mRNA in living cells using<sup> </sup>molecular beacon (MB) technology. Confocal-FRAP measurements<sup> </sup>determined that the transport of influenza A virus intronless<sup> </sup>mRNA, in both nucleus and cytoplasm, was energy dependent, being<sup> </sup>similar to that of Poly(A)<sup>+</sup> RNA. Drug inhibition studies in<sup> </sup>living cells revealed that the export of influenza A virus mRNA<sup> </sup>is independent of the CRM1 pathway, while the function of RNA<sup> </sup>polymerase II (RNAP-II) may be needed. In addition, viral NS1<sup> </sup>protein and cellular TAP protein were found associated with<sup> </sup>influenza A virus mRNA in the cell nucleus. These findings characterize<sup> </sup>influenza A virus mRNA transport in living cells and suggest<sup> </sup>that influenza A virus mRNA may be exported from the nucleus<sup> </sup>by the cellular TAP/p15 pathway with NS1 protein and RNAP-II<sup> </sup>participation.<sup> </sup>
<!-- null -->
<table width="100%" bgcolor="#e1e1e1" cellpadding="0" cellspacing="0"> <tbody><tr><td valign="middle" width="5%" align="left" bgcolor="#ffffff">
</td> <th valign="middle" width="95%" align="left">[SIZE=+2] INTRODUCTION [/SIZE]</th></tr></tbody></table> <table align="right" border="1" cellpadding="5"><tbody><tr><th align="left">[SIZE=-1]
[/SIZE]</th></tr></tbody></table>
Influenza virus is one of the few RNA viruses to synthesize<sup> </sup>its mRNA in the nucleus of infected cells (1). The virus mRNAs<sup> </sup>are potential substrates for the cellular splicing machinery<sup> </sup>and need to be exported from the nucleus to enable the viral<sup> </sup>proteins to be synthesized (2). Uncovering the mechanisms of<sup> </sup>influenza virus mRNA export is of great importance to truly<sup> </sup>understand the replication and pathogenicity of the virus. The<sup> </sup>nuclear export of cellular mRNA is mediated by several proteins<sup> </sup>that bind to mRNA and to pre-mRNA precursors (3). However, unlike<sup> </sup>cellular intron-containing mRNAs, most influenza virus mRNAs<sup> </sup>are intronless. Hence, the export mechanisms of viral intronless<sup> </sup>mRNAs might be different from those of cellulr mRNAs. Moreover,<sup> </sup>because there are three different types of influenza virus mRNA,<sup> </sup>more than one mechanism of nuclear export might operate in virus-infected<sup> </sup>cells (1). The first type of influenza virus mRNA includes intronless<sup> </sup>mRNAs, such as PA, PB1, PB2, HA, NA and NP mRNA. The second<sup> </sup>type of viral mRNA consists of the M1 and NS1 mRNAs, which contain<sup> </sup>introns but do not undergo splicing. The M2 and NS2 mRNAs, which<sup> </sup>are produced by splicing, comprise the third type of viral mRNA.<sup> </sup>The mechanisms of the nuclear export of these three types of<sup> </sup>influenza A virus mRNA remain unknown.<sup> </sup>
Two pathways have been described that appear to be responsible<sup> </sup>for the export of viral mRNA (4). The first RNA export pathway<sup> </sup>was the CRM1 pathway, which is utilized by human immunodeficiency<sup> </sup>virus (HIV) through the mediation of the Rev protein (5). Herpes<sup> </sup>simplex virus (HSV) also utilizes CRM1 to export its mRNA (6).<sup> </sup>However, other studies showed that CRM1 may be not a major contributor<sup> </sup>to mRNA export in metazoans or yeast (7,8). The human protein<sup> </sup>TAP, and its yeast ortholog Mex67p, might be the best candidates<sup> </sup>for mRNA export receptors because they shuttle between the nucleus<sup> </sup>and cytoplasm, cross-link to poly(A)<sup>+</sup> RNA, localize at the nuclear<sup> </sup>pores and interact directly with nucleoporins (9?12).<sup> </sup>The TAP pathway was reported to be used by HSV ICP27 to export<sup> </sup>its intronless mRNAs (4). Moreover, TAP protein could also promote<sup> </sup>the export of constitutive transport element (CTE) containing<sup> </sup>transcripts of some virus such as type D retrovirus (9,10,13).<sup> </sup>Influenza A virus mRNA may, therefore, be exported from the<sup> </sup>nucleus by the CRM1 dependent pathway or by the TAP/p15 pathway.<sup> </sup>Previous studies have shown that influenza virus NS1 protein<sup> </sup>could selectively inhibit cellular mRNA export by binding with<sup> </sup>CPSF and PABII (1), or by forming an inhibitory complex with<sup> </sup>cellular mRNA export factors TAP and p15 (14). Moreover, NS1<sup> </sup>can also inhibit the splicing and export of its own mRNA, in<sup> </sup>an RNA binding-dependent manner (2). Nevertheless, the mechanisms<sup> </sup>by which influenza virus mRNAs are exported from the nucleus<sup> </sup>and the roles of viral NS1 protein in influenza A virus intronless<sup> </sup>mRNA export are still unclear.<sup> </sup>
The ability to accurately and repeatedly track mRNA in living<sup> </sup>mammalian cells would help us to fully understand the mRNA transport<sup> </sup>mechanism. There are a variety of tools currently used to visualize<sup> </sup>intracellular mRNAs, including molecular beacons (MBs) and fluorescently<sup> </sup>labeled oligonucleotide probes. MBs are a powerful and simple<sup> </sup>tool for cellular mRNA and viral RNA visualization in living<sup> </sup>cells (15?21). Live-cell imaging of mRNA could shed light<sup> </sup>on many fundamental processes, such as the kinetics of mRNA<sup> </sup>production, mRNA localization and transportation inside a cell<sup> </sup>and cellular responses to virus infection and to virus?host<sup> </sup>interaction. We, therefore, used MBs as a detection probe to<sup> </sup>track influenza A virus mRNA in living host cells, in order<sup> </sup>to explore the mechanisms of viral mRNA export.<sup> </sup>
In this study, we successfully visualized influenza A virus<sup> </sup>mRNA in living mammalian cells, and studied the dynamic behaviors<sup> </sup>of influenza virus mRNA by Confocal-FRAP experiments. By imaging<sup> </sup>experiments of living cells and protein immunofluorescence analysis<sup> </sup>in fixed cells, it was found that influenza A virus mRNAs could<sup> </sup>colocalize with viral NS1 and cellular TAP protein in cell nucleus.<sup> </sup>Moreover, coimmunoprecipitation experiments of influenza A virus<sup> </sup>mRNAs with NS1 and TAP protein revealed that NS1 and TAP protein<sup> </sup>could be physically associated with both intron-containing and<sup> </sup>intronless mRNAs of influenza A virus. By performing Actinomycin<sup> </sup>D (ActD) inhibition experiments in living cells we observed<sup> </sup>that RNA polymerase II (RNAP-II) and other factors might be<sup> </sup>involved in influenza virus mRNA export. Furthermore, Leptomycin<sup> </sup>B (LMB), a specific inhibitor of CRM1, could not inhibit influenza<sup> </sup>A virus mRNA export in living cells. Therefore, influenza A<sup> </sup>virus mRNA export may be independent of CRM1. Together, these<sup> </sup>results indicate that the cellular transport of influenza A<sup> </sup>virus mRNA may be energy dependent and utilize the cellular<sup> </sup>TAP/p15 transport pathway with the participation of viral NS1<sup> </sup>protein and cellular RNAP-II.
free full text
Imaging and characterizing influenza A virus mRNA transport in living cells
<nobr>Wei Wang<sup>1</sup><sup>,2</sup></nobr>, <nobr>Zong-Qiang Cui<sup>1</sup></nobr>, <nobr>Han Han<sup>1</sup><sup>,2</sup></nobr>, <nobr>Zhi-Ping Zhang<sup>1</sup></nobr>, <nobr>Hong-Ping Wei<sup>1</sup></nobr>, <nobr>Ya-Feng Zhou<sup>1</sup></nobr>, <nobr>Ze Chen<sup>1</sup></nobr> and <nobr>Xian-En Zhang<sup>1</sup><sup>,*</sup></nobr> <sup>1</sup>State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071 and <sup>2</sup>Graduate School, Chinese Academy of Sciences, Beijing 100039, China
[SIZE=-1]*To whom correspondence should be addressed. Tel: +86 10 5888 1508; Fax: +86 10 5888 1559; Email: x.zhang@wh.iov.cn<script type="text/javascript"><!-- var u = "x.zhang", d = "wh.iov.cn"; document.getElementById("em0").innerHTML = '<a href="mailto:' + u + '@' + d + '">' + u + '@' + d + '<\/a>'//--></script>[/SIZE]
[SIZE=-1]Received April 4, 2008.[/SIZE] [SIZE=-1]Revised June 23, 2008.[/SIZE] [SIZE=-1]Accepted July 8, 2008.[/SIZE]
<!-- null -->
<table width="100%" bgcolor="#e1e1e1" cellpadding="0" cellspacing="0"> <tbody><tr><td valign="middle" width="5%" align="left" bgcolor="#ffffff">
[/SIZE]</th></tr></tbody></table>
The mechanisms of influenza A virus mRNA intracellular transport<sup> </sup>are still not clearly understood. Here, we visualized the distribution<sup> </sup>and transport of influenza A virus mRNA in living cells using<sup> </sup>molecular beacon (MB) technology. Confocal-FRAP measurements<sup> </sup>determined that the transport of influenza A virus intronless<sup> </sup>mRNA, in both nucleus and cytoplasm, was energy dependent, being<sup> </sup>similar to that of Poly(A)<sup>+</sup> RNA. Drug inhibition studies in<sup> </sup>living cells revealed that the export of influenza A virus mRNA<sup> </sup>is independent of the CRM1 pathway, while the function of RNA<sup> </sup>polymerase II (RNAP-II) may be needed. In addition, viral NS1<sup> </sup>protein and cellular TAP protein were found associated with<sup> </sup>influenza A virus mRNA in the cell nucleus. These findings characterize<sup> </sup>influenza A virus mRNA transport in living cells and suggest<sup> </sup>that influenza A virus mRNA may be exported from the nucleus<sup> </sup>by the cellular TAP/p15 pathway with NS1 protein and RNAP-II<sup> </sup>participation.<sup> </sup>
<!-- null -->
<table width="100%" bgcolor="#e1e1e1" cellpadding="0" cellspacing="0"> <tbody><tr><td valign="middle" width="5%" align="left" bgcolor="#ffffff">
[/SIZE]</th></tr></tbody></table>
Influenza virus is one of the few RNA viruses to synthesize<sup> </sup>its mRNA in the nucleus of infected cells (1). The virus mRNAs<sup> </sup>are potential substrates for the cellular splicing machinery<sup> </sup>and need to be exported from the nucleus to enable the viral<sup> </sup>proteins to be synthesized (2). Uncovering the mechanisms of<sup> </sup>influenza virus mRNA export is of great importance to truly<sup> </sup>understand the replication and pathogenicity of the virus. The<sup> </sup>nuclear export of cellular mRNA is mediated by several proteins<sup> </sup>that bind to mRNA and to pre-mRNA precursors (3). However, unlike<sup> </sup>cellular intron-containing mRNAs, most influenza virus mRNAs<sup> </sup>are intronless. Hence, the export mechanisms of viral intronless<sup> </sup>mRNAs might be different from those of cellulr mRNAs. Moreover,<sup> </sup>because there are three different types of influenza virus mRNA,<sup> </sup>more than one mechanism of nuclear export might operate in virus-infected<sup> </sup>cells (1). The first type of influenza virus mRNA includes intronless<sup> </sup>mRNAs, such as PA, PB1, PB2, HA, NA and NP mRNA. The second<sup> </sup>type of viral mRNA consists of the M1 and NS1 mRNAs, which contain<sup> </sup>introns but do not undergo splicing. The M2 and NS2 mRNAs, which<sup> </sup>are produced by splicing, comprise the third type of viral mRNA.<sup> </sup>The mechanisms of the nuclear export of these three types of<sup> </sup>influenza A virus mRNA remain unknown.<sup> </sup>
Two pathways have been described that appear to be responsible<sup> </sup>for the export of viral mRNA (4). The first RNA export pathway<sup> </sup>was the CRM1 pathway, which is utilized by human immunodeficiency<sup> </sup>virus (HIV) through the mediation of the Rev protein (5). Herpes<sup> </sup>simplex virus (HSV) also utilizes CRM1 to export its mRNA (6).<sup> </sup>However, other studies showed that CRM1 may be not a major contributor<sup> </sup>to mRNA export in metazoans or yeast (7,8). The human protein<sup> </sup>TAP, and its yeast ortholog Mex67p, might be the best candidates<sup> </sup>for mRNA export receptors because they shuttle between the nucleus<sup> </sup>and cytoplasm, cross-link to poly(A)<sup>+</sup> RNA, localize at the nuclear<sup> </sup>pores and interact directly with nucleoporins (9?12).<sup> </sup>The TAP pathway was reported to be used by HSV ICP27 to export<sup> </sup>its intronless mRNAs (4). Moreover, TAP protein could also promote<sup> </sup>the export of constitutive transport element (CTE) containing<sup> </sup>transcripts of some virus such as type D retrovirus (9,10,13).<sup> </sup>Influenza A virus mRNA may, therefore, be exported from the<sup> </sup>nucleus by the CRM1 dependent pathway or by the TAP/p15 pathway.<sup> </sup>Previous studies have shown that influenza virus NS1 protein<sup> </sup>could selectively inhibit cellular mRNA export by binding with<sup> </sup>CPSF and PABII (1), or by forming an inhibitory complex with<sup> </sup>cellular mRNA export factors TAP and p15 (14). Moreover, NS1<sup> </sup>can also inhibit the splicing and export of its own mRNA, in<sup> </sup>an RNA binding-dependent manner (2). Nevertheless, the mechanisms<sup> </sup>by which influenza virus mRNAs are exported from the nucleus<sup> </sup>and the roles of viral NS1 protein in influenza A virus intronless<sup> </sup>mRNA export are still unclear.<sup> </sup>
The ability to accurately and repeatedly track mRNA in living<sup> </sup>mammalian cells would help us to fully understand the mRNA transport<sup> </sup>mechanism. There are a variety of tools currently used to visualize<sup> </sup>intracellular mRNAs, including molecular beacons (MBs) and fluorescently<sup> </sup>labeled oligonucleotide probes. MBs are a powerful and simple<sup> </sup>tool for cellular mRNA and viral RNA visualization in living<sup> </sup>cells (15?21). Live-cell imaging of mRNA could shed light<sup> </sup>on many fundamental processes, such as the kinetics of mRNA<sup> </sup>production, mRNA localization and transportation inside a cell<sup> </sup>and cellular responses to virus infection and to virus?host<sup> </sup>interaction. We, therefore, used MBs as a detection probe to<sup> </sup>track influenza A virus mRNA in living host cells, in order<sup> </sup>to explore the mechanisms of viral mRNA export.<sup> </sup>
In this study, we successfully visualized influenza A virus<sup> </sup>mRNA in living mammalian cells, and studied the dynamic behaviors<sup> </sup>of influenza virus mRNA by Confocal-FRAP experiments. By imaging<sup> </sup>experiments of living cells and protein immunofluorescence analysis<sup> </sup>in fixed cells, it was found that influenza A virus mRNAs could<sup> </sup>colocalize with viral NS1 and cellular TAP protein in cell nucleus.<sup> </sup>Moreover, coimmunoprecipitation experiments of influenza A virus<sup> </sup>mRNAs with NS1 and TAP protein revealed that NS1 and TAP protein<sup> </sup>could be physically associated with both intron-containing and<sup> </sup>intronless mRNAs of influenza A virus. By performing Actinomycin<sup> </sup>D (ActD) inhibition experiments in living cells we observed<sup> </sup>that RNA polymerase II (RNAP-II) and other factors might be<sup> </sup>involved in influenza virus mRNA export. Furthermore, Leptomycin<sup> </sup>B (LMB), a specific inhibitor of CRM1, could not inhibit influenza<sup> </sup>A virus mRNA export in living cells. Therefore, influenza A<sup> </sup>virus mRNA export may be independent of CRM1. Together, these<sup> </sup>results indicate that the cellular transport of influenza A<sup> </sup>virus mRNA may be energy dependent and utilize the cellular<sup> </sup>TAP/p15 transport pathway with the participation of viral NS1<sup> </sup>protein and cellular RNAP-II.